Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03711643
Other study ID # 2017_84
Secondary ID 2018-A01673-52
Status Recruiting
Phase N/A
First received
Last updated
Start date May 7, 2019
Est. completion date December 2021

Study information

Verified date September 2020
Source University Hospital, Lille
Contact Philippe Puech, MD,PhD
Phone 03 20 44 59 54
Email philippe.puech@chru-lille.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The prostatic biopsies echo-guided are a painful and stressful. The purpose is to test a new medical device created recently, " Hypnos-Pro ", wich uses connected technologies. This connected device is a mask with diodes coupled with an audio headset and a touch pad. This connected mask is an another option to induce an hypnotic state for our patients. the objective is to value hypnotic mask effectiveness, to reduce the level pain and anxiety for the patients who benefit a prostatic biopsies echo-guided with local anesthesia.


Recruitment information / eligibility

Status Recruiting
Enrollment 172
Est. completion date December 2021
Est. primary completion date December 2021
Accepts healthy volunteers No
Gender Male
Age group 50 Years to 75 Years
Eligibility Inclusion Criteria:

- Patient eligible for prostate biopsies

- Having accepted and signed the consent, for performing a prostate biopsy ultrasound examination

- No contraindication to the gesture

- Supporting the left lateral decubitus

Exclusion Criteria:

- Patient isolation contact / droplets

- Patient with hearing and / or epilepticus and / or dementia and / or having a history of stroke and / or allergic to lidocaine

- Person unable to consent, or benefiting from a system of legal protection (tutelage / curatorship).

- Patients with epileptic seizures.

- Patients with known allergies to plastics and other resins that may develop allergic contact dermatitis.

- Patients who are hypersensitive to radio frequency.

- Patients with Rocephin administration before the gesture

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Periprostatic nerve block
4 injections of 2 cc of lidocaine for a Periprostatic nerve block
Device:
hypnosis mask
The mask HYPNOS pro stimulates the imagination of the user by means of 6 diodes among 3 by eye. Just before the introduction of ultrasound probe, the patient put the hypnotic mask and choose a session.Twenty minutes after the removal of the probe, an healthworker assess the painful patient with the visual analogue scale VAS, after this the patient fulfill the STATE- TRAIT Anxiety Inventory (STAI) form Y-A.

Locations

Country Name City State
France Hôpital Claude Huriez, CHU Lille

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual analogic Scale Measure the pain in the scale from 0 to 10 at 20 minutes after the removal of the probe
Secondary State-Trait Anxiety Inventory ou STAI forme Y-A Baseline, at 20 minutes after the removal of the probe
Secondary Percentage of positive response of satisfaction of the patient The question is: Would you do prostate biopsy punctures under the same conditions in a month? (Yes: effective method, No: ineffective method). at 20 minutes after the removal of the probe
Secondary Percentage of positive response of satisfaction of the operator The question is: In your opinion, has the gesture been made optimally? (Yes/ No). at 20 minutes after the removal of the probe
See also
  Status Clinical Trial Phase
Completed NCT00941343 - Benign Prostatic Hyperplasia in Taiwan N/A
Completed NCT00575913 - Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study Phase 4
Completed NCT02074644 - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia N/A
Active, not recruiting NCT03344757 - Health Gatherings - For Your Health After Cancer N/A
Terminated NCT02606123 - Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer Phase 1/Phase 2
Not yet recruiting NCT02245334 - A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy Phase 4
Active, not recruiting NCT01464216 - MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Not yet recruiting NCT05574647 - Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer N/A
Completed NCT03192917 - Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy N/A
Completed NCT03104907 - Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer N/A
Completed NCT03099421 - Prostatic Artery Embolization for Benign Prostatic Obstruction N/A
Completed NCT00853710 - Test Semiquantitative Prostate Specific Antigen (PSA) N/A
Completed NCT01316458 - Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy Phase 2
Recruiting NCT05413850 - Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection Phase 1/Phase 2
Completed NCT05941260 - Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics
Terminated NCT02031029 - Character Traits and Stress in Suspected Prostate Cancer N/A
Completed NCT00484783 - Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery N/A
Terminated NCT00672009 - A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer Phase 2
Approved for marketing NCT04452136 - Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer